Blackhawk Capital Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,850
Closed -$308K 309
2018
Q2
$308K Sell
1,850
-250
-12% -$40.1K 0.35% 74
2018
Q1
$353K Buy
2,100
+100
+5% +$16.8K 0.3% 71
2017
Q4
$327K Buy
+2,000
New +$359K 0.28% 82

Other funds holding AGN

Blackhawk Capital Partners's AGN Position: Q3 2018 in Review

Blackhawk Capital Partners sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 1,850 shares — an estimated $308K sold.

Blackhawk Capital Partners first reported a position in AGN in Q4 2017 and held it in 3 quarters. The position peaked at $353K in Q1 2018. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Blackhawk Capital Partners reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Blackhawk Capital Partners sold 1,850 Allergan plc shares in Q3 2018, an estimated $308K.
  • Blackhawk Capital Partners first reported a position in Allergan plc in Q4 2017 and held it in 3 quarters.
  • Blackhawk Capital Partners's Allergan plc position peaked at $353K in Q1 2018.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Blackhawk Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.